Nimesh A. Patel, MD, explains why myopia-related retinal detachments are appearing earlier and how routine exams can catch ...
Cathleen McCabe, MD, presents real-world data from a 57-site US study of the enVista Aspire IOL at ESCRS 2026, reporting over ...
Tarcocimab, tabirafusp-ted were noninferior to aflibercept in DAYBREAK wet AMD trial; 54% on tarcocimab reached 24-week dosing.
Alessandro Arrigo, MD, describes an early-stage method that uses blue light autofluorescence imaging to grade cataracts objectively. He explains why a reproducible score could help with surgeon ...
Study found anti-VEGF therapy was linked to kidney function decline in patients with diabetic retinopathy or retinal vein ...
At Retina Society 2026, Emily Eton, MD, discusses a 10-center study finding similar exudate control in Coats disease and ...
Christina Y. Weng, MD, MBA, FASRS, highlights findings showing statin use reduced PVR risk by 25% in a propensity-matched ...
Nimesh A. Patel, MD, discusses compounded low-dose atropine and SYD-101 ahead of an October 30 FDA advisory committee meeting ...
Charles Wykoff, MD, PhD, reviews LUGANO safety and treatment burden data, including a 42% injection reduction with vorolanib ...
Three residents were honored for their leadership, education and research, and patient care contributions in ophthalmology, ...
Subretinal drusenoid deposits (SDDs) in age-related macular degeneration may flag severe aortic stenosis that increases ...
Patient enrollment is complete in the the ASTRA phase 3 study AURN001 to treat corneal edema associated with corneal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results